請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/49296
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃筱鈞(Hsiao-Chun Huang) | |
dc.contributor.author | Wei-An Chen | en |
dc.contributor.author | 陳韋安 | zh_TW |
dc.date.accessioned | 2021-06-15T11:22:35Z | - |
dc.date.available | 2017-08-25 | |
dc.date.copyright | 2016-08-25 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-17 | |
dc.identifier.citation | 1. Marusyk, A. and K. Polyak, Tumor heterogeneity: causes and consequences. Biochim Biophys Acta, 2010. 1805(1): p. 105-17.
2. Burrell, R.A., et al., The causes and consequences of genetic heterogeneity in cancer evolution. Nature, 2013. 501(7467): p. 338-45. 3. Shackleton, M., et al., Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell, 2009. 138(5): p. 822-9. 4. Gatenby, R.A., R.J. Gillies, and J.S. Brown, Of cancer and cave fish. Nat Rev Cancer, 2011. 11(4): p. 237-8. 5. Welch, J.S., et al., The origin and evolution of mutations in acute myeloid leukemia. Cell, 2012. 150(2): p. 264-78. 6. Klein, C.A., Selection and adaptation during metastatic cancer progression. Nature, 2013. 501(7467): p. 365-72. 7. Singh, S.K., et al., Identification of human brain tumour initiating cells. Nature, 2004. 432(7015): p. 396-401. 8. Wu, X., et al., Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature, 2012. 482(7386): p. 529-33. 9. Nik-Zainal, S., et al., The life history of 21 breast cancers. Cell, 2012. 149(5): p. 994-1007. 10. Campbell, P.J., et al., The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature, 2010. 467(7319): p. 1109-13. 11. Junttila, M.R. and F.J. de Sauvage, Influence of tumour micro-environment heterogeneity on therapeutic response. Nature, 2013. 501(7467): p. 346-54. 12. Chu, Y.W., et al., Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol, 1997. 17(3): p. 353-60. 13. Chen, J.J., et al., Global analysis of gene expression in invasion by a lung cancer model. Cancer Res, 2001. 61(13): p. 5223-30. 14. Bonnet, D. and J.E. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 1997. 3(7): p. 730-7. 15. Singh, S.K., et al., Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003. 63(18): p. 5821-8. 16. Al-Hajj, M., et al., Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 2003. 100(7): p. 3983-8. 17. O'Brien, C.A., et al., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007. 445(7123): p. 106-10. 18. Li, C., et al., Identification of pancreatic cancer stem cells. Cancer Res, 2007. 67(3): p. 1030-7. 19. Zhang, S., et al., Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res, 2008. 68(11): p. 4311-20. 20. Matsui, W., et al., Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res, 2008. 68(1): p. 190-7. 21. Winey, M., et al., Three-dimensional ultrastructural analysis of the Saccharomyces cerevisiae mitotic spindle. J Cell Biol, 1995. 129(6): p. 1601-15. 22. Wittmann, T., A. Hyman, and A. Desai, The spindle: a dynamic assembly of microtubules and motors. Nat Cell Biol, 2001. 3(1): p. E28-34. 23. Gadde, S. and R. Heald, Mechanisms and molecules of the mitotic spindle. Curr Biol, 2004. 14(18): p. R797-805. 24. Vale, R.D., The molecular motor toolbox for intracellular transport. Cell, 2003. 112(4): p. 467-80. 25. Dagenbach, E.M. and S.A. Endow, A new kinesin tree. J Cell Sci, 2004. 117(Pt 1): p. 3-7. 26. Sawin, K.E., et al., Mitotic spindle organization by a plus-end-directed microtubule motor. Nature, 1992. 359(6395): p. 540-3. 27. Sharp, D.J., et al., The bipolar kinesin, KLP61F, cross-links microtubules within interpolar microtubule bundles of Drosophila embryonic mitotic spindles. J Cell Biol, 1999. 144(1): p. 125-38. 28. Heald, R., Motor function in the mitotic spindle. Cell, 2000. 102(4): p. 399-402. 29. Morrison, S.J. and J. Kimble, Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 2006. 441(7097): p. 1068-74. 30. Yamashita, Y.M., et al., Polarity in stem cell division: asymmetric stem cell division in tissue homeostasis. Cold Spring Harb Perspect Biol, 2010. 2(1): p. a001313. 31. Gomez-Lopez, S., R.G. Lerner, and C. Petritsch, Asymmetric cell division of stem and progenitor cells during homeostasis and cancer. Cell Mol Life Sci, 2014. 71(4): p. 575-97. 32. Hwang, W.L., et al., MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol, 2014. 16(3): p. 268-80. 33. Bu, P., et al., A miR-34a-Numb Feedforward Loop Triggered by Inflammation Regulates Asymmetric Stem Cell Division in Intestine and Colon Cancer. Cell Stem Cell, 2016. 18(2): p. 189-202. 34. Sugiarto, S., et al., Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell, 2011. 20(3): p. 328-40. 35. Lathia, J.D., et al., Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis, 2011. 2: p. e200. 36. Cicalese, A., et al., The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell, 2009. 138(6): p. 1083-95. 37. Bajaj, J., B. Zimdahl, and T. Reya, Fearful symmetry: subversion of asymmetric division in cancer development and progression. Cancer Res, 2015. 75(5): p. 792-7. 38. Derivery, E., et al., Polarized endosome dynamics by spindle asymmetry during asymmetric cell division. Nature, 2015. 528(7581): p. 280-5. 39. Farhadifar, R., et al., Scaling, selection, and evolutionary dynamics of the mitotic spindle. Curr Biol, 2015. 25(6): p. 732-40. 40. Hara, Y. and A. Kimura, Cell-size-dependent spindle elongation in the Caenorhabditis elegans early embryo. Curr Biol, 2009. 19(18): p. 1549-54. 41. Loughlin, R., et al., Katanin contributes to interspecies spindle length scaling in Xenopus. Cell, 2011. 147(6): p. 1397-407. 42. Wuhr, M., et al., Evidence for an upper limit to mitotic spindle length. Curr Biol, 2008. 18(16): p. 1256-61. 43. Tsai, W.Y., Spindle Scaling and Orientation in Symmetric and Asymmetric Cell Division, in Institute of Molecular and Cellular Biology. 2016, National Taiwan University. 44. Fischer, M., et al., p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes. PLoS One, 2013. 8(5): p. e63187. 45. Goshima, G. and J.M. Scholey, Control of mitotic spindle length. Annu Rev Cell Dev Biol, 2010. 26: p. 21-57. 46. Straight, A.F., J.W. Sedat, and A.W. Murray, Time-lapse microscopy reveals unique roles for kinesins during anaphase in budding yeast. J Cell Biol, 1998. 143(3): p. 687-94. 47. Burbank, K.S., T.J. Mitchison, and D.S. Fisher, Slide-and-cluster models for spindle assembly. Curr Biol, 2007. 17(16): p. 1373-83. 48. Haraguchi, T., T. Kaneda, and Y. Hiraoka, Dynamics of chromosomes and microtubules visualized by multiple-wavelength fluorescence imaging in living mammalian cells: effects of mitotic inhibitors on cell cycle progression. Genes Cells, 1997. 2(6): p. 369-80. 49. Hewitt, R.E., et al., Validation of a model of colon cancer progression. J Pathol, 2000. 192(4): p. 446-54. 50. Cai, S., et al., Kinesin-14 family proteins HSET/XCTK2 control spindle length by cross-linking and sliding microtubules. Mol Biol Cell, 2009. 20(5): p. 1348-59. 51. Fanali, C., et al., Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. World J Gastroenterol, 2014. 20(4): p. 923-42. 52. Li, Z., CD133: a stem cell biomarker and beyond. Exp Hematol Oncol, 2013. 2(1): p. 17. 53. Ren, F., W.Q. Sheng, and X. Du, CD133: a cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol, 2013. 19(17): p. 2603-11. 54. Zoller, M., CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer, 2011. 11(4): p. 254-67. 55. Feng, J.M., et al., Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line. Cancer Biol Ther, 2012. 13(14): p. 1396-406. 56. Hsu, C.S., et al., Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620. PLoS One, 2013. 8(4): p. e61133. 57. Fan, F., et al., The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells. Br J Cancer, 2015. 112(3): p. 539-46. 58. Lee, J., et al., Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 2006. 9(5): p. 391-403. 59. Pastrana, E., V. Silva-Vargas, and F. Doetsch, Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell, 2011. 8(5): p. 486-98. 60. Ponti, D., et al., Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 2005. 65(13): p. 5506-11. 61. Ricci-Vitiani, L., et al., Identification and expansion of human colon-cancer-initiating cells. Nature, 2007. 445(7123): p. 111-5. 62. Todaro, M., et al., Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell, 2007. 1(4): p. 389-402. 63. Qureshi-Baig, K., et al., What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue. PLoS One, 2016. 11(1): p. e0146052. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/49296 | - |
dc.description.abstract | 在生物演化的過程中,細胞產生變異以適應不同環境,而癌症的演化亦然。癌細胞中存在高度基因不穩定性(genomic instability),導致其對基因的限制降低,因而使基因突變或功能失調的機率提高,是令癌症具有基因異質性(heterogeneous)以及促進癌症演化的主要原因。本實驗室先前的研究發現,隨著癌症演化,紡錘體(spindle)的型態在細胞有絲分裂中期(metaphase)產生了極大的變化。侵略能力(invasive ability)較弱的人類肺腺癌細胞株CL1-0中紡錘體的型態較短胖;而透過人工篩選出具有較高侵略能力的惡性子細胞株(subline)CL1-5則具有較瘦長的紡錘體。本試驗目的乃找出癌症演化過程中,導致紡錘體型態差異的關鍵因子,並研究此一調控因子在細胞分裂中扮演的角色。首先在細胞的移動能力試驗(transwell migration assay)的結果顯示,CL1-5較CL1-0具有高移動能力。此外,應用微陣列分析(microarray)以及反轉錄即時定量聚合酶鏈鎖反應(RT-qPCR),我們發現一微管調控子驅動蛋白5(Kinesin-5)在CL1-5細胞中的表現量顯著提升,甚至為CL1-0的兩倍。本研究也設計在CL1-0細胞株中過量表現驅動蛋白5,結果造成CL1-0在分裂中期的紡錘體型態變得較為瘦長,並與CL1-5極為相似。此等結果證實驅動蛋白5在癌細胞演化過程中紡錘體型態的差異上扮演關鍵角色。近年來,癌症幹細胞(cancer stem cell)的假說在癌症演化的研究中佔有一席之地。癌症幹細胞被指出能夠自我更新(self-renewal)以及細胞分化(differentiation),並具備有形成腫瘤的潛力。其中癌症幹細胞調控不對稱分裂(asymmetric cell division )的能力,被指出可能與腫瘤惡性程度相關。透過驅動蛋白5參與在細胞分裂中的機制為暗示,我們認為紡錘體及微管調控子是控制癌症幹細胞不對稱分裂的關鍵因素。最後本試驗擬以大腸癌幹細胞為模式,研究紡錘體參與不對稱分裂的關鍵機制。透過球形成試驗(sphere-forming assay),已成功自大腸癌細胞株HCT116及HT29培養出大腸癌症幹細胞(colorectal cancer stem cells, CCSCs),並發現相較於母細胞株,其幹細胞標記Sox2、Oct4、Nanog及Lgr5基因表現量均顯著上升。初步實驗也發現,少數紡錘體調控因子的基因表現量在大腸癌幹細胞與大腸癌細胞間存在顯著差異。未來將利用聚合酶連鎖反應微陣列分析(PCR array),探討大腸癌幹細胞與一般大腸癌細胞株的差異,進而找出紡錘體參與不對稱分裂的關鍵機制。 | zh_TW |
dc.description.abstract | During evolution, cells phenotypically change and optimize themselves to adapt to the different environment. This kind of phenomenon also happen in cancer evolution as a result of the heterogeneity within tumor. We were interested in the case of evolution of metastatic cancer, and we approached the question with a lung cancer cell line CL1-0 and it highly metastatic subline, CL1-5. Although CL1-5 has a smaller cell size, the spindle of the metastatic CL1-5 was longer than CL1-0, conflicting with the idea that spindle length should correlate with cell size. By transwell migration assay, we confirm that CL1-5 exists higher migration ability than CL1-0. Furthermore, to identify the key regulator involved, we employed microarray analysis and found that Kinesin-5, a microtubule regulator, was up-regulated in G2 phase CL1-5, and the near two-fold up-regulation was confirmed by RT-qPCR. To address whether Kinesin-5 play a role in metaphase spindle scaling in human cancer cells, we ectopically expressed Kinesin-5 in CL1-0 and found that metaphase spindle became CL1-5-like. Collectively, our data demonstrate that up-regulation of Kinesin-5 can lead to lengthened metaphase spindle. For the past few years, cancer stem cell (CSC), a population of cancer cells with stemness properties, took its place in the field of cancer evolution. We were also interested in how the expression of spindle regulators might be altered in CSCs. This was based on the reasoning that CSCs might be dysregulated in the balance of symmetric versus asymmetric cell division, in which spindle regulators might play a definitive role. By sphere-forming assay, we had successfully isolated colorectal CSCs from HCT116 and HT29 cell lines, and found escalated expression of Sox2, Oct4, Nanog and Lgr5, which are stemness-associated genes. Several spindle regulators also show different expression level between isolated CSCs and its parental cells. We will continue to compare the expression of spindle regulators in colorectal CSCs and non-CSCs, with the hope to identify key molecules whose dysregulation might lead to the most devastating aspect of cancer. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T11:22:35Z (GMT). No. of bitstreams: 1 ntu-105-R03b43034-1.pdf: 10321181 bytes, checksum: ea71f8c16a6f554fec373bd55c5f9a91 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 致謝 i
中文摘要 iii Abstract v Table of Contents vii List of Figures ix 1. Introduction 1 1-1. Overview of cancer evolution 1 1-1-1. Cancer evolution and tumor heterogeneity 1 1-1-2. Intratumor heterogeneity and tumor metastasis 1 1-1-3. CL1 and it metastatic subpopulations by artificial selection in vitro 3 1-1-4. Cancer stem cell model in cancer evolution 3 1-2. Cell division 4 1-2-1. Cell division and mitosis 4 1-2-2. Function of mitotic spindles during mitosis 6 1-2-3. Motor proteins are essential for spindle orientation 7 1-2-4. Symmetric and asymmetric cell division 7 1-2-5. Asymmetric cell division in disease 8 1-2-6. Spindle regulator orient in asymmetric cell division 9 2. Material and method 10 2-1. Cell culture and synchronization 10 2-2. Cloning strategy and transfection 10 2-3. Immunofluorescence staining 11 2-4. Transwell migration assay 11 2-5. Flow cytometry and fluorescence-activated cell sorting (FACS) 11 2-6. Sphere forming assay 12 2-7. RNA extraction and RT-qPCR 12 3. Result and discussion 14 3-1. Spindle regulators in cancer cells 14 3-1-1. Expression of spindle regulator Kinesin-5 correlates with the phenotypically changed in CL1-0 and CL1-5 14 3-1-2. Kinesin-5 governs spindle scaling in CL series 15 3-1-3. Different expression of Kinesin-5 in SW480 and it metastasis subline SW620 also lead to a morphological change in spindle 16 3-2. Spindle regulators in cancer stem cells (CSCs). 17 3-2-1. CD133 and CD44 selection is not appropriate to isolate CCSCs from CRC cell lines in our system. 17 3-2-2. Isolation of CCSCs from CRC cell lines by sphere-forming assay 19 3-2-3. Sphere-derived cancer stem cells (SDCSCs) show expression of stemness protein. 19 3-2-4. Spindle regulators are differently expressed between SDCSCs and parental cells 20 4. Conclusion and future work 22 5. Reference 24 | |
dc.language.iso | en | |
dc.title | 探討癌細胞與癌幹細胞中紡錘體調控因子與細胞分裂的關係 | zh_TW |
dc.title | Identification of Spindle Regulators in Cancer and Cancer Stem Cells Division | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 呂仁(Jean Lu),林劭品(Shau-Ping Lin),朱家瑩(Chia-Ying Chu) | |
dc.subject.keyword | 癌症演化,癌症幹細胞,細胞分裂,不對稱分裂,紡錘體,驅動蛋白5, | zh_TW |
dc.subject.keyword | cancer evolution,cancer stem cell,cell division,asymmetric cell division,spindle,Kinesin-5, | en |
dc.relation.page | 41 | |
dc.identifier.doi | 10.6342/NTU201603118 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-08-19 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 分子與細胞生物學研究所 | zh_TW |
顯示於系所單位: | 分子與細胞生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 10.08 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。